The Prevalence and Effects of Alzheimers Disease Among American Women
Description of Topic for Dissertation Research
At present, there are more than 5 million cases of Alzheimers disease in the United States, and this figure is projected to increase by 300% by mid-century (Vega et al., 2017). Although the Food and Drug Administration recently approved the first medicinal treatment for Alzheimers disease, its efficacy remains unknown at present and it is reasonable to suggest that many Americans will continue to suffer from this disorder as they grow older. While Alzheimers disease can occur at any time during the lifespan, it is generally regarded as an age-related disorder since it typically occurs among the elderly and represents the most common cause of dementia in this population (Beckman & Morrison, 2021). Despite a small decline in life expectancy rates attributable to the ongoing Covid-19 pandemic in recent years, people are still living longer today and ever before in history. Therefore, it is also reasonable to posit that unless and until the precise causes of Alzheimers disease are identified and efficacious treatments become widely available, the number of Alzheimers disease sufferers will continue to increase well into the foreseeable future (Beckman & Morrison, 2021).
. What is known for certain at present is that women have a higher lifetime incidence of Alzheimers disease compared to men (Peeters et al., 2022). Researchers have also determined that Alzheimers disease currently affects almost 50 million people globally, and that fully two-thirds of the cases in the United States are women (Beckman & Morrison, 2021). Moreover, the female population in the United States is becoming far more diverse, and the prevalence of Alzheimers disease among African American and Hispanic women is also higher compared to men, with the largest differences existing among the same ethnicity (Royse et al., 2021). In addition, African American women are also less likely to seek medical assistance when the symptoms of Alzheimers first occur, thereby exacerbating the condition and accelerating its devastating effects on the human mind and body (Lincoln et al., 2021). Taken together, these issues make the study of the prevalence and effects of Alzheimers disease among American women a timely and interesting topic that warrants further investigation.
Annotated List of Juried Articles
Andrew, M. K. & Tierney, M. C. (2018). The puzzle of sex, gender and Alzheimers disease: Why are women more often affected than men? Womens Health, 14, 1-8.
This study cites the significant differences in the incidence and prevalence of Alzheimers disease between men and women as a problem that warrants additional investigation. The purpose of the study was to provide a comprehensive, critical analysis of these issues using a narrative review to identify gender- and sex-based influences in the onset of Alzheimers disease. In this regard, the authors note that there are multiple sex differences between men and women with respect to hormones, pregnancy and brain structure that may have an influence on the onset of Alzheimers disease. The findings that emerged from this study included the effects of longevity because women tend to outlive men as well as other biological differences such as hormonal and physicality which may play a role. In addition, gendered social roles and educational and employment opportunities may also be implicated in the onset of Alzheimers disease. Based on these findings, the authors suggest that additional research concerning the manner in which sex- and gender-based differences combine to place women at greater risk of developing Alzheimers compared to men. Likewise, the authors also call for further studies to determine how sex and gender should be taken into account for the optimal management of this disorder. A minor weakness in this study was the minimal discussion concerning the relationship between female frailty and the onset of Alzheimers although this factor was included in the calculus.
Kimura, A. et al. (2019). Malnutrition is Associated with Behavioral and Psychiatric Symptoms of Dementia in Older Women with Mild Cognitive Impairment and Early-Stage Alzheimers Disease. Nutrients, 11(8), 1951-1966.
This article emphasizes the fact that the worlds population is living longer with a concomitant increase in the prevalence of various...
…the onset of Alzheimers. Likewise, the high rates of diabetes among the Latino population in the U.S. may also increase the risk of developing Alzheimers. Based on these and other findings, the authors conclude that it is possible that the combination of the various social determinants of health account for the current disparities in the prevalence of Alzheimers disease among the Latino population in the United States. As a result, the authors recommend that additional research be conducted in this area to isolate the most significant determinant so that these disparities can be reduced or even eliminated.Additional Women and Alzheimers Disease Articles
Beckman, D., & Morrison, J. H. (2021). Towards developing a rhesus monkey model of early Alzheimers disease focusing on womens health. American Journal of Primatology, 83(11), 17.
de Lange, A. G. (2020, August). Women's brain aging: Effects of sex-hormone exposure, pregnancies, and genetic risk for Alzheimer's disease. Human Brain Mapping, 41(18), 5141-5150.
Dubal, D. B. (2020). Sex difference in Alzheimer's disease: An updated, balanced and emerging perspective on differing vulnerabilities. Handbook of Clinical Neurology, 175, 261-273.
Kimura, A. et al. (2019). Malnutrition is Associated with Behavioral and Psychiatric Symptoms of Dementia in Older Women with Mild Cognitive Impairment and Early-Stage Alzheimers Disease. Nutrients, 11, 1951.
Peeters, G., Katelekha, K., Lawlor, B., & Demnitz, N. (2022). Sex differences in the incidence and prevalence of young?onset Alzheimers disease: A meta?analysis. International Journal of Geriatric Psychiatry, 37(1), 19.
Sanfilippo, C. (2019, May 15). Middle-aged healthy women and Alzheimer's disease patients present an overlapping of brain cell transcriptional profile. Neuroscience, 406(15), 333-344.
Savolainen-Peltonen, H. (2019, March 6). Use of postmenopausal hormone therapy and risk of Alzheimers disease in Finland: nationwide case-control study. BMJ, 364(8190), l665-1672.
Song, Y. J. et al. (2020, March 10). The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis. Frontiers of Neuroendocrinology, 14, 1-13.
Subramaniapillai, S. et al. (2021, January). Sex and gender differences in cognitive and brain reserve: Implications for Alzheimers disease in women. Frontiers of Neuroendocrinology, 60, 100879.
Zhu, D. et al. (2021). Alzheimers pathogenic mechanisms and underlying…
References
Beckman, D., & Morrison, J. H. (2021). Towards developing a rhesus monkey model of early Alzheimer’s disease focusing on women’s health. American Journal of Primatology, 83(11), 1–7.
Lincoln, K. D., Chow, T., Gaines, B. F., & Fitzgerald, T. (2021). Fundamental causes of barriers to participation in Alzheimer’s clinical research among African Americans. Ethnicity & Health, 26(4), 585–599.
Majoka, M. A. & Schimming, C. (2022, June). Effect of Social Determinants of Health on Cognition and Risk of Alzheimer Disease and Related Dementias. Clinical Therapeutics, 43(6), 922-929.
Peeters, G., Katelekha, K., Lawlor, B., & Demnitz, N. (2022). Sex differences in the incidence and prevalence of young?onset Alzheimer’s disease: A meta?analysis. International Journal of Geriatric Psychiatry, 37(1), 1–9.
Royse, S. K., Cohen, A. D., Snitz, B. E., & Rosano, C. (2021). Differences in Alzheimer’s Disease and Related Dementias Pathology Among African American and Hispanic Women: A Qualitative Literature Review of Biomarker Studies. Frontiers in Systems Neuroscience, 15, 685957.
Vega, I. E. et al. (2017). Alzheimer’s Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health. Journal of Alzheimer’s Disease, 58(4), 979-992.
ALZHEIMER'S DISEASE Examining the potential use of beta secretase enzymes in the treatment of Alzheimer's Disease Examining the potential use of beta secretase enzymes in the treatment of Alzheimer's Disease Efforts to develop a drug for Alzheimer's disease, which mostly affect people in older age, have not been successful. Instead, most of the treatments offered often target the behavioral symptoms of the affected individual, but not the cause of the disease. The occurrence
Alzheimer Healthy Community PLANNED, PERSONALIZED CARE Alzheimer's Healthy Community Dog-Assisted Therapy for Older People with Dementia A review of nine studies on the subject produced loose conclusions on the value of this type of therapy (Perkins et al., 2008). They, however, established a trend, indicating increased social behavior and decreased agitation when dogs were in the company of the respondents. This improvement in social behavior was unrelated with the severity of the respondents' dementia.
What is worth noting here is the fact that behavior disturbances, ranging in severity from repeated questioning to physical violence, are common (National Institute of Mental Health, 1989). It is unclear whether Alzheimer's disease represents a single entity or several variants. Some experts believe that there are distinct subtypes of Alzheimer's disease, such as Lewy body disease (in which the signs of Parkinson's disease, visual hallucinations or alterations in alertness
Some treatments may actually help with the disease. Diets and dietary supplements Eating vegetables like broccoli and spinach may help older women [and probably men] retain some memory abilities later on, while avoiding obesity in middle age lowers the risk of later Alzheimer's disease in both sexes, new studies suggest." The effect of the vegetables probably comes from the antioxidants and B. vitamins they contain (Ritter, 2004). Herbal remedies and other dietary
Alzheimer's Disease currently affects more than four million Americans. Alzheimer's is a disease characterized by the progressive degeneration of areas within the brain, resulting in cognitive and physical decline that will eventually lead to death. It is important to emphasize that Alzheimer's disease (AD) is not a normal part of aging. Although AD typically appears in those over sixty-five, it is a neurodegenerative disease, quite distinct from any aging-related cognitive
Scientists are racing to find a cure as millions of people reach the age when Alzheimer's is most commonly manifested (Plontz). Experts are still trying to fully understand the cause or causes of Alzheimer's disease. In the meantime, it's helpful to understand the hallmarks of Alzheimer's -- plaques and tangles -- and the risk factors that affect a person's likelihood of developing the disease (Hill). Alzheimer's disease is characterized by a
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now